Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Results available

A Study of Guselkumab in Participants With Active Psoriatic Arthritis

ClinicalTrials.gov ID: NCT04882098

Public ClinicalTrials.gov record NCT04882098. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Subcutaneously Administered Guselkumab in Improving the Signs and Symptoms and Inhibiting Radiographic Progression in Participants With Active Psoriatic Arthritis

Study identification

NCT ID
NCT04882098
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
1,054 participants

Conditions and interventions

Interventions

  • Guselkumab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 16, 2021
Primary completion
Dec 29, 2024
Completion
Oct 4, 2027
Last update posted
May 7, 2026

2021 – 2027

United States locations

U.S. sites
23
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
Rheumatology Associates Birmingham Alabama 35205
Arizona Arthritis and Rheumatology Research PLLC Flagstaff Arizona 86001-6218
Arizona Arthritis & Rheumatology Associates PC Glendale Arizona 85306
Arizona Arthritis & Rheumatology Research, PLLC Tucson Arizona 85704
Advanced Medical Research La Palma California 90624
Rheumatology Center of San Diego San Diego California 92128
Medvin Clinical Research, Inc. Whittier California 90606
Heuer M.D. Research Orlando Florida 32819
The Arthritis Center, Inc. Palm Harbor Florida 34684
Forcare Clinical Research Inc Tampa Florida 33624
Klein And Associates M D P A Hagerstown Maryland 21740
Advanced Rheumatology Okemos Michigan 48864
Arthritis Consultants St Louis Missouri 63141
Glacier View Research Institute Kalispell Montana 59901-3158
NYU Langone Ambulatory Care Brooklyn Heights Brooklyn New York 11201
PMG Research of Salisbury Salisbury North Carolina 28144
STAT Research, Inc. Springboro Ohio 45342
Altoona Center For Clinical Research Duncansville Pennsylvania 16635
Dr. Ramesh Gupta Memphis Tennessee 38119
Austin Regional Clinic Austin Texas 78731
Adriana Pop Moody MD Clinic PA Corpus Christi Texas 78404
Southwest Rheumatology Research LLC Mesquite Texas 75150
Arthritis And Osteoporosis Clinic Waco Texas 76710

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 257 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04882098, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04882098 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →